Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury
Main Authors: | Pere Boadas-Vaello, Enrique Verdú |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=9;spage=1390;epage=1392;aulast=Boadas-Vaello |
Similar Items
-
Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.
by: Xavier Xifró, et al.
Published: (2015-01-01) -
Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection
by: Chun-Yuan Cheng, et al.
Published: (2021-03-01) -
Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
by: Katja Herges, et al.
Published: (2011-01-01) -
Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice
by: Sílvia Castany, et al.
Published: (2019-03-01) -
Effect of α-Glucosylation on the Stability, Antioxidant Properties, Toxicity, and Neuroprotective Activity of (–)-Epigallocatechin Gallate
by: Jose L. Gonzalez-Alfonso, et al.
Published: (2019-03-01)